We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
David
Simmons
More information about this study, what is involved and how to take part can be found on the study website.
Gestational diabetes
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
When Diabetes Mellitus is first found during pregnancy it is called Gestational Diabetes Mellitus (GDM). Women with GDM have high levels of glucose (sugar) in their blood. This can have severe consequences for mothers and their children. Prevention of GDM is therefore important. The main aim of this study is to evaluate the effects of three interventions to prevent GDM.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2013 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/23829946 protocol2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26112044 results2017 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/28882133 process evaluation2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29540227 cost-effectiveness results2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31182492 results (added 15/04/2020)2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31845115/ review (added 28/05/2020)2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32069353/ results (added 05/01/2021)
You can take part if:
You may not be able to take part if:
1. Pre-existing diabetes2. Diagnosed with (gestational) diabetes mellitus before randomisation, defined as fasting glucose ≥ 5.1 mmol/l and/or 1 hour glucose ≥ 10 mmol/l and/or 2 hour glucose ≥ 8.5 mmol/l at baseline3. Not able to walk at least 100 meters safely4. Requirement for complex diets5. Advanced chronic conditions (eg valvular heart disease)6. Sgnificant psychiatric disease7. Unable to speak major language of the country of recruitment fluently8. Known abnormal calcium metabolism (hypo/hyperparathyroidism, nephrolithiasis, hypercalciuria) or hypercalciuria detected at screening (0.6 mmol/mmol creatinine in spot morning urine)9. Twin pregnancy
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
David
Simmons
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by VU University Medical Center (Netherlands) and funded by Seventh Framework Programme.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.